Trends in prescription opioid use in pediatric emergency department patients

Pediatric Emergency Care

Volumn 30, Issue 4, 2014, Pages 230-235

  Mazer Amirshahi, Maryann ^a,b,c   Mullins, Peter M ^b   Rasooly, Irit R ^b   Van Den Anker, John ^a,b   Pines, Jesse M ^a,b  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

opioid analgesics; pediatric emergency department; prescribing trends

Indexed keywords

CODEINE; HYDROCODONE; HYDROMORPHONE; MORPHINE; OXYCODONE; NARCOTIC ANALGESIC AGENT;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ANALGESIA; CAUCASIAN; CHILD; CHILDHOOD DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG USE; EMERGENCY CARE; EMERGENCY PATIENT; EMERGENCY WARD; FEMALE; HEALTH CARE SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MUSCULOSKELETAL PAIN; OTALGIA; PAIN; PRESCRIPTION; PRIVATE HEALTH INSURANCE; RACE DIFFERENCE; SEX DIFFERENCE; TOOTH PAIN; TREND STUDY; EMERGENCY HEALTH SERVICE; HEALTH SURVEY; PEDIATRICS; STATISTICS AND NUMERICAL DATA; TRENDS; YOUNG ADULT;

ADOLESCENT; ANALGESICS, OPIOID; DRUG PRESCRIPTIONS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEALTH SURVEYS; HUMANS; MALE; PAIN; PAIN MANAGEMENT; PEDIATRICS; YOUNG ADULT;

EID: 84898483112     PISSN: 07495161     EISSN: 15351815     Source Type: Journal    
DOI: 10.1097/PEC.0000000000000102     Document Type: Conference Paper

References (39)

1. Cantrill SV, Brown MD, Carlisle RJ, et al. Clinical policy: critical issues in the prescribing of opioids for adult patients in the emergency department. Ann Emerg Med. 2012;60:499-525.
2. Phillips DM. JCAHO pain management standards are unveiled. Joint Commission on Accreditation of Healthcare Organizations. JAMA. 2000;284:428-429.
3. Committee on Pediatric Emergency Medicine and Section on Anesthesiology and Pain Medicine. American Academy of Pediatrics. Fein JA, Zempsky WT, Cravero JP. Relief of pain and anxiety in pediatric patients in emergency medical systems. Pediatrics. 2012;130: e1391Ye1405.
4. Craig KD, Lilley CM, Gilbert CA. Social barriers to optimal pain management in infants and children. Clin J Pain. 1996;12:232-242.
5. American Academy of Pediatrics. Committee on Psychosocial Aspects of Child and Family Health. Task Force on Pain in Infants, Children, and Adolescents. The assessment and management of acute pain in infants, children, and adolescents. Pediatrics. 2001;108:793-797.
6. Bhargava R, Young KD. Procedural pain management patterns in academic pediatric emergency departments. Acad Emerg Med. 2007;14: 479-482.
7. Pletcher MJ, Kertesz SG, Kohn MA, et al. Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments. JAMA. 2008;299:70-78.
8. Fortuna RJ, Robbins BW, Caiola E, et al. Prescribing of controlled medications to adolescents and young adults in the United States. Pediatrics. 2010;126:1108-1116.
9. Manchikanti L, Helm S 2nd, Fellows B, et al. Opioid epidemic in the United States. Pain Physician. 2012;15:ES9-ES38.
10. Manchikanti L, Singh A. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician. 2008;11:S63YS88.
11. Drug poisoning deaths in the United States, 1980-2008. 2011. Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/nchs/data/ databriefs/db81.pdf. Accessed December 12, 2012.
12. Johnston L, O'Malley P, Bachman J, et al. Monitoring the future national survey results on drug use, 1975-2008: volume I, secondary school students. NIH Publication 09-742. Bethesda, MD: National Institute on Drug Abuse, 2009.
13. Substance abuse and mental health services administration. Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-41, HHS Publication No. (SMA) 11-4658. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2010.
14. McCabe SE, West BT, Teter CJ, et al. Medical and nonmedical use of prescription opioids among high school seniors in the United States. Arch Pediatr Adolesc Med. 2012;166:797-802.
15. Garnier LM, Arria AM, Caldeira KM, et al. Sharing and selling of prescription medications in a college student sample. J Clin Psychiatry. 2010;71:262-269.
16. McCabe SE, Cranford JA, West BT. Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: results from two national surveys. Addict Behav. 2008;33:1297-1305.
17. Sung HE, Richter L, Vaughan R, et al. Nonmedical use of prescription opioids among teenagers in the United States: trends and correlates. J Adolesc Health. 2005;37:44-51.
18. US Food and Drug Administration. Information for healthcare professionals: use of codeine in nursing mothers. 2007. Available at: http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ucm124889.htm. Accessed December 17, 2012.
19. US Food and Drug Administration. FDA Drug safety communication: codeine use in certain children after tonsillectomy and/or adenoidectomy may lead to rare, but life-threatening adverse events or death. 2007. Available at: www.fda.gov/drugs/drugsafety/ucm313631.htm. Accessed December 17, 2012.
20. Kelly LE, Rieder M, van den Anker J, et al. More codeine fatalities after tonsillectomy in North American children. Pediatrics. 2012;129: e1343Y-1347.
21. Ciszkowski C, Madadi P, Phillips MS, et al. Codeine, ultrarapid- metabolism genotype, and postoperative death. N Engl J Med. 2009;361:827-828.
22. Koren G, Cairns J, Chitayat D, et al. Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother. Lancet. 2006;368:704.
23. McCaig LF, McLemore T. Plan and operation of the National Hospital Ambulatory Medical Survey. Series 1: programs and collection procedures. Vital Health Stat 1. 1994;1-78.
24. Wightman R, Perrone J, Portelli I, et al. Likeability and abuse liability of commonly prescribed opioids. J Med Toxicol. 2012;8:335-340.
25. Arria AM, Garnier-Dykstra LM, Caldeira KM, et al. Prescription analgesic use among young adults: adherence to physician instructions and diversion. Pain Med. 2011;12:898-903.
26. Meier EA, Troost JP, Anthony JC. Extramedical use of prescription pain relievers by youth aged 12 to 21 years in the United States: national estimates by age and by year. Arch Pediatr Adolesc Med. 2012;166: 803-807.
27. Tormoehlen LM, Mowry JB, Bodle JD, et al. Increased adolescent opioid use and complications reported to a poison control center following the 2000 JCAHO pain initiative. Clin Toxicol (Phila). 2011;49:492-498.
28. Osgood ED, Eaton TA, Trudeau JJ, et al. A brief survey to characterize oxycodone abuse patterns in adolescents enrolled in two substance abuse recovery high schools. Am J Drug Alcohol Abuse. 2012;38: 166-170.
29. Boyd CJ, Esteban McCabe S, Teter CJ. Medical and nonmedical use of prescription pain medication by youth in a Detroit-area public school district. Drug Alcohol Depend. 2006;81:37-45.
30. McCabe SE, Boyd CJ, Young A. Medical and nonmedical use of prescription drugs among secondary school students. J Adolesc Health. 2007;40:76-83.
31. Anderson KO, Green CR, Payne R. Racial and ethnic disparities in pain: causes and consequences of unequal care. J Pain. 2009;10:1187-1204.
32. Sullivan MD, Edlund MJ, Fan MY, et al. Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: the TROUP Study. Pain. 2010;150:332-339.
33. Gugelmann H, Perrone J, Nelson L. Windmills and pill mills: can PDMPs tilt the prescription drug epidemic? J Med Toxicol. 2012;8: 378-386.
34. Baehren DF, Marco CA, Droz DE, et al. A statewide prescription monitoring program affects emergency department prescribing behaviors. Ann Emerg Med. 2010;56:19,23.e1-23.e3.
35. The NSDUH report: nonmedical use of pain relievers in substate regions: 2008 to 2010. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Available at: http://www.samhsa.gov/data/2k12/NSDUH113/ SR113StateSubUseDisorder2012.htm. Accessed January 10, 2010.
36. Banta-Green CJ. Adolescent abuse of pharmaceutical opioids raises questions about prescribing and prevention. Arch Pediatr Adolesc Med. 2012;166:865-866.
37. US Food and Drug Administration. Draft blueprint for prescriber education for long-acting/extended-release opioid class-wide REMS. Fed Reg. 2011;76:68766.
38. Neven DE, Sabel JC, Howell DN, et al. The development of the Washington State emergency department opioid prescribing guidelines. J Med Toxicol. 2012;8:353-359.
39. Schaeffer T. Abuse-deterrent formulations, an evolving technology against the abuse and misuse of opioid analgesics. J Med Toxicol. 2012;8:400-407.